18 samples
Export
<<<Page of 1 >>>
Accession Title Sample type Organism(s) Ch Platform Series Supplementary Contact Release date
Remove filtersFilter Remove filterGSE261880
GSM8153455
Control1
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153456
Control2
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153457
Control3
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153458
Erlotinib1
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153459
Erlotinib2
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153460
Erlotinib3
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153461
Erlotinib+PR1
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153462
Erlotinib+PR2
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153463
Erlotinib+PR3
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153464
Gefitinib1
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153465
Gefitinib2
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153466
Gefitinib3
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153467
Gefitinib+PR1
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153468
Gefitinib+PR2
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153469
Gefitinib+PR3
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153470
PR1
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153471
PR2
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024
GSM8153472
PR3
SRA 1
  • Link icon GSE261880
Haeseung Lee Mar 24, 2024